Translation, validation, and psychometric evaluation of the Italian version of the facial clinimetric evaluation (FaCE) scale for patients with peripheral facial palsy.
Saved in:
| Title: | Translation, validation, and psychometric evaluation of the Italian version of the facial clinimetric evaluation (FaCE) scale for patients with peripheral facial palsy. |
|---|---|
| Authors: | Nizzoli, Federica (AUTHOR), Losi, Elisabetta (AUTHOR), Bergamini, Maria Vittoria (AUTHOR), Bonali, Marco (AUTHOR), Alicandri-Ciufelli, Matteo (AUTHOR), Marchioni, Daniele (AUTHOR), Galeazzi, Gian Maria (AUTHOR), Pingani, Luca (AUTHOR), Reggiani, Elena (AUTHOR) |
| Source: | Acta Oto-Laryngologica. Apr2025, Vol. 145 Issue 4, p355-361. 7p. |
| Subjects: | Multitrait multimethod techniques, Research methodology evaluation, Translations, Research evaluation, Descriptive statistics, Psychometrics, Research methodology, Facial paralysis, Factor analysis |
| Abstract (English): | Background: In the management of patients with peripheral facial palsy, it is essential to have tools that allow patients to tell what their facial disabilities are. Objective: This study aimed to translate and validate the FaCE scale into Italian (I-FaCE). Material and methods: The FaCE scale was translated into Italian using a three-stage process. The draft was reviewed for comprehensibility by SLTs and revised accordingly. The beta version of I-FaCE was administered to 200 patients. Internal consistency was measured using McDonald's omega, while test-retest reliability was assessed with a fifteen-day interval between administrations. Confirmatory factor analysis (CFA) was performed to evaluate construct validity. Concurrent validity was tested by correlating I-FaCE scores with the House-Brackmann Scale, Sunnybrook Scale, and FDI Scale. Results: The I-FaCE demonstrated excellent internal consistency (McDonald's omega = 0.87) and strong test-retest reliability. CFA indicated a good model fit, with indices such as CFI (0.94), TLI (0.91), RMSEA (0.07), and RMSR (0.06). Concurrent validity showed significant correlations between I-FaCE and other grading systems. Conclusion and significance: I-FaCE is a valid and reliable tool to assess the impact of facial dysfunction on quality of life. Its adoption will facilitate better patient care and enable meaningful comparisons with international data. [ABSTRACT FROM AUTHOR] |
| Abstract (Chinese): | 在治疗周围性面瘫患者时, 必须有办法让患者能够描述自己的面部残疾。 本研究旨在将 FaCE 量表翻译成意大利语 (I-FaCE) 并进行验证。 使用三阶段流程将FaCE 量表翻译成意大利语。SLT 审查了草稿的可理解性并进行了相应修改。I-FaCE 的测试版已用于 200 名患者。使用 McDonald的omega 测量内部一致性, 同时评估测试-重测信度, 两次测试间隔 15 天。进行验证性因子分析 (CFA) 以评估结构效度。通过将 I-FaCE 得分与 House-Brackmann 量表、Sunnybrook 量表和 FDI 量表相关联来测试并发效度。 I-FaCE 表现出极好的内部一致性(McDonald的omega = 0.87)和强大的测试-重测信度。 CFA 表明模型拟合度良好, 指标包括 CFI(0.94)、TLI(0.91)、RMSEA(0.07)和 RMSR(0.06)。并发效度显示 I-FaCE 与其他评分系统之间存在显著相关性。 I-FaCE 是评估面部功能障碍对生活质量影响的有效且可靠的工具。它的采用将有助于更好地护理患者, 并能够与国际数据进行有意义的比较。 [ABSTRACT FROM AUTHOR] |
| Copyright of Acta Oto-Laryngologica is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Background: In the management of patients with peripheral facial palsy, it is essential to have tools that allow patients to tell what their facial disabilities are. Objective: This study aimed to translate and validate the FaCE scale into Italian (I-FaCE). Material and methods: The FaCE scale was translated into Italian using a three-stage process. The draft was reviewed for comprehensibility by SLTs and revised accordingly. The beta version of I-FaCE was administered to 200 patients. Internal consistency was measured using McDonald's omega, while test-retest reliability was assessed with a fifteen-day interval between administrations. Confirmatory factor analysis (CFA) was performed to evaluate construct validity. Concurrent validity was tested by correlating I-FaCE scores with the House-Brackmann Scale, Sunnybrook Scale, and FDI Scale. Results: The I-FaCE demonstrated excellent internal consistency (McDonald's omega = 0.87) and strong test-retest reliability. CFA indicated a good model fit, with indices such as CFI (0.94), TLI (0.91), RMSEA (0.07), and RMSR (0.06). Concurrent validity showed significant correlations between I-FaCE and other grading systems. Conclusion and significance: I-FaCE is a valid and reliable tool to assess the impact of facial dysfunction on quality of life. Its adoption will facilitate better patient care and enable meaningful comparisons with international data. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 00016489 |
| DOI: | 10.1080/00016489.2024.2447039 |
